Esperion Therapeutics, Inc. (NASDAQ:ESPR) Q3 2025 Earnings Call Transcript November 6, 2025
Esperion Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.15812 EPS, expectations were $-0.09.
Operator: Hello, ladies and gentlemen, and thank you for standing by. Welcome to Esperion’s Third Quarter 2025 Financial Results. [Operator Instructions] Please be advised that today’s conference is being recorded. I would now like to hand the conference over to Alina Venezia, Head of...
